Demographic change is predicted to increase emergency hospital admissions and length of emergency visits

The aging population and emergency departments

 

Boston, NE, USA (July 8, 2013) – As the population gets older, and the baby boomers begin to enter their 60’s and 70’s, one might assume that the number of trips to the emergency department will also increase. This is contradicted by new research from Brigham and Women’s Hospital (BWH), which shows that population aging will not cause the number of emergency department (ED) visits to increase between now and 2050. However, visits will become longer and hospitalizations will become more frequent. This research will appear in the July issue of Health Affairs.

 

"With US emergency care characterized as ‚at the breaking point‘, we wanted to study how the aging of the U.S. population would affect the demand for emergency department services and hospitalizations in the coming decades," explained Daniel J. Pallin, MD, MPH, director of research in the Department of Emergency Medicine at BWH and lead author of this study. "We found that demographic change will not cause the number of ED visits to increase, but visits will get longer and there will be more hospitalizations."

 

To study the effect of aging on demand for ED services, the researchers quantified the number of visits that would occur if the structure of the U.S. population changed, but everything else remained the same. They used 2009 as the baseline to model the expected ED use for each age and race subgroup. They then applied these visit rates to the population the US Census Bureau expects to exist in future years, through 2050. The main outcome measure was the ratio of the rate of increase in ED visits to the rate of increase in total population. Researchers were surprised – and reassured – to find that the number of ED visits would increase only at the same rate as the population increased. However, they also found that the aggregate amount of time patients spend in EDs nationwide will increase 10 percent faster than population growth, due to longer visits. More worrisome still, they predict that hospital admissions from the ED will increase 23 percent faster than population growth.

 

"Our analysis predicts that the total amount of time spent by patients in EDs across the country will increase 1.1 times faster than population growth as the population ages," explained Pallin. "This means that the United States will need 10 percent more ED resources per capita than available today." Pallin says the most important take home message for this research is that since the length-of-stay and number of hospitalizations are predicted to increase, the process of moving patients from the ED into the hospital needs to be as efficient as possible.

 

Researchers note that the principal limitation of this investigation is the scope of the research. The researchers only predicted changes in healthcare based on demographic change, and assumed that all other factors would remain stable (like whether a given person will choose to visit the ED instead of a doctor’s office). Also, they did not analyze hospitalizations that come from anywhere else besides the ED; other hospitalizations account for roughly 55 percent of the total.

 

 

This research was supported by a seed grant from the Brigham and Women’s Hospital Department of Emergency Medicine.

 

Brigham and Women’s Hospital (BWH) is a 793-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare. BWH has more than 3.5 million annual patient visits, is the largest birthing center in New England and employs more than 15,000 people. The Brigham’s medical preeminence dates back to 1832, and today that rich history in clinical care is coupled with its national leadership in patient care, quality improvement and patient safety initiatives, and its dedication to research, innovation, community engagement and educating and training the next generation of health care professionals. Through investigation and discovery conducted at its Biomedical Research Institute (BRI), BWH is an international leader in basic, clinical and translational research on human diseases, involving nearly 1,000 physician-investigators and renowned biomedical scientists and faculty supported by nearly $625 million in funding. BWH continually pushes the boundaries of medicine, including building on its legacy in organ transplantation by performing the first face transplants in the U.S. in 2011. BWH is also home to major landmark epidemiologic population studies, including the Nurses‘ and Physicians‘ Health Studies, OurGenes and the Women’s Health Initiative. For more information and resources, please visit BWH’s online newsroom.

 


 

Brigham and Women’s Hospital, 08.07.2013 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…